Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier
- PMID: 23600747
- DOI: 10.3109/1061186X.2012.757769
Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier
Abstract
High-density lipoprotein (HDL) particles can deliver cholesterol from peripheral tissues to the liver through apolipoprotein A1 (Apo A1), which specifically binds to the scavenger receptor class B type 1 (SR-B1) receptor on the surface of hepatocytes. Therefore, ApoA1 can be potentially used to target drugs to the liver. In this study, we successfully loaded doxorubicin hydrochloride (Dox or Dox-HCl), which is a hydrophilic drug used in a wide variety of clinical applications, into the core of reconstituted HDL (rHDL prepared by apoAI and egg phospholipids) to form a doxorubicin-HDL complex (rHDL-Dox). The MTT assays showed that rHDL-Dox particles also had higher cytotoxicity against several cells lines compared to free drug or Dox encapsulated into liposomes. A cellular uptake assay demonstrated that rHDL-Dox had higher absorption in SR-BI receptor positive liver cells. Importantly, in vivo experiments showed that rHDL-Dox can reduce tumor growth more effectively than liposomes. In addition, an in vitro hemolysis assay showed that rHDL-Dox caused only limited hemolysis in the case of high doses. Taken together, our findings indicate that rHDL is a safe and effective drug delivery system for targeting liver.
Similar articles
-
Recombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecin.Cancer Lett. 2010 Dec 1;298(1):26-33. doi: 10.1016/j.canlet.2010.05.023. Epub 2010 Jun 25. Cancer Lett. 2010. PMID: 20579804
-
Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.J Drug Target. 2014 Jan;22(1):76-85. doi: 10.3109/1061186X.2013.839687. Epub 2013 Oct 4. J Drug Target. 2014. PMID: 24093636
-
Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.Int J Pharm. 2013 Nov 18;456(2):315-24. doi: 10.1016/j.ijpharm.2013.08.071. Epub 2013 Sep 7. Int J Pharm. 2013. PMID: 24016742
-
Evaluation of reconstituted high-density lipoprotein (rHDL) as a drug delivery platform - a detailed survey of rHDL particles ranging from biophysical properties to clinical implications.Nanomedicine. 2016 Oct;12(7):2161-2179. doi: 10.1016/j.nano.2016.05.009. Epub 2016 May 26. Nanomedicine. 2016. PMID: 27237620 Review.
-
Reconstituted HDL as a therapeutic delivery device.Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Nov;1866(11):159025. doi: 10.1016/j.bbalip.2021.159025. Epub 2021 Aug 8. Biochim Biophys Acta Mol Cell Biol Lipids. 2021. PMID: 34375767 Free PMC article. Review.
Cited by
-
Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting.Pharmaceuticals (Basel). 2023 May 29;16(6):802. doi: 10.3390/ph16060802. Pharmaceuticals (Basel). 2023. PMID: 37375753 Free PMC article. Review.
-
Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo.Biomedicines. 2022 Apr 14;10(4):900. doi: 10.3390/biomedicines10040900. Biomedicines. 2022. PMID: 35453650 Free PMC article.
-
High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.ACS Nano. 2016 Mar 22;10(3):3015-41. doi: 10.1021/acsnano.5b07522. Epub 2016 Feb 25. ACS Nano. 2016. PMID: 26889958 Free PMC article. Review.
-
Tuning the surface coating of IONs toward efficient sonochemical tethering and sustained liberation of topoisomerase II poisons.Int J Nanomedicine. 2019 Sep 17;14:7609-7624. doi: 10.2147/IJN.S208810. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31571866 Free PMC article.
-
Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.Cancer Treat Res. 2015;166:129-50. doi: 10.1007/978-3-319-16555-4_6. Cancer Treat Res. 2015. PMID: 25895867 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous